Connection
Joshua Yarrow to Prevalence
This is a "connection" page, showing publications Joshua Yarrow has written about Prevalence.
|
|
Connection Strength |
|
 |
|
 |
|
0.148 |
|
|
|
-
Peterson MD, Belakovskiy A, McGrath R, Yarrow JF. Testosterone Deficiency, Weakness, and Multimorbidity in Men. Sci Rep. 2018 04 12; 8(1):5897.
Score: 0.099
-
Messer JG, Jiron JM, Mendieta Calle JL, Castillo EJ, Israel R, Phillips EG, Yarrow JF, Van Poznak C, Kesavalu L, Kimmel DB, Aguirre JI. Zoledronate treatment duration is linked to bisphosphonate-related osteonecrosis of the jaw prevalence in rice rats with generalized periodontitis. Oral Dis. 2019 May; 25(4):1116-1135.
Score: 0.026
-
Conover CF, Yarrow JF, Garrett TJ, Ye F, Quinlivan EP, Cannady DF, Peterson MD, Borst SE. High Prevalence of Low Serum Biologically Active Testosterone in?Older Male Veterans. J Am Med Dir Assoc. 2017 Apr 01; 18(4):366.e17-366.e24.
Score: 0.023